Humulin M3 (Mixture 3) 100 IU/ml Suspension for Injection in cartridge

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

Human insulin (recombinant dna origin)

Available from:

Eli Lilly Nederland B.V.

ATC code:

A10AD; A10AD01

INN (International Name):

Human insulin (recombinant dna origin)

Dosage:

100 international unit(s)/millilitre

Pharmaceutical form:

Suspension for injection in cartridge

Prescription type:

Product subject to prescription which may be renewed (B)

Therapeutic area:

Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting; insulin (human)

Authorization status:

Marketed

Authorization date:

2015-03-13

Patient Information leaflet

PACKAGE LEAFLET: INFORMATION FOR THE USER
HUMULIN
® M3 (MIXTURE 3) 100 IU/ML SUSPENSION FOR INJECTION IN
CARTRIDGE
(Insulin human)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may
harm them, even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any
possible side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Humulin M3 is and what it is used for
2.
What you need to know before you use Humulin M3
3.
How to use Humulin M3
4.
Possible side effects
5.
How to store Humulin M3
6.
Contents of the pack and other information
1.
WHAT HUMULIN M3 IS AND WHAT IT IS USED FOR
Humulin M3 contains the active substance human insulin, which is used
to treat diabetes.
You get diabetes if your pancreas does not make enough insulin to
control the level of
glucose in your blood (blood sugar). Humulin M3 is used to control
glucose in the long term.
It is a premixed suspension of rapid and long acting insulin. Its
action is prolonged by the
inclusion of protamine sulfate in the suspension.
Your doctor may tell you to use Humulin M3 as well as a longer-acting
insulin. Each kind of
insulin comes with its own patient information leaflet to tell you
about it. Do not change your
insulin unless your doctor tells you to. Be very careful if you do
change insulin. Each type of
insulin has a different colour and symbol on the pack and the
cartridge so that you can easily
tell the difference.
2 .
WHAT YOU NEED TO KNOW BEFORE YOU USE HUMULIN M3
HUMULIN M3 IN CARTRIDGES IS ONLY SUITABLE FOR INJECTING JUST UNDER THE SKIN
USING A
REUSABLE PEN. SPEAK TO YOUR DOCTOR IF YOU NEED TO INJECT YOUR INSULIN
BY ANOTHER METHOD.
DO NOT USE HUMULIN M3:
-
IF YO

Summary of Product characteristics

Health Products Regulatory Authority
09 November 2020
CRN009V6Z
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Humulin M3 (Mixture 3) 100 IU/ml Suspension for Injection in cartridge
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml contains 100 IU insulin human (produced in _E. coli_ by
recombinant DNA technology).
One cartridge contains 3 ml equivalent to 300 IU of biphasic isophane
insulin – 30 % soluble insulin / 70 % isophane insulin.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
A suspension for injection in a cartridge.
Humulin M3 is a sterile suspension of human insulin in the proportion
of 30 % soluble insulin to 70 % isophane insulin.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For the treatment of patients with diabetes mellitus who require
insulin for the maintenance of glucose homeostasis.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
The dosage should be determined by the physician, according to the
requirement of the patient.
_Paediatric population_
No data are available
Method of administration
Humulin M3 in cartridges is only suitable for subcutaneous injections
from a reusable pen. This formulation should not be
administered intravenously.
Subcutaneous administration should be in the upper arms, thighs,
buttocks or abdomen. Use of injection sites should be
rotated so that the same site is not used more than approximately once
a month in order to reduce the risk of lipodystrophy
and cutaneous amyloidosis (see section 4.4 and 4.8).
Care should be taken when injecting any Humulin insulin preparations
to ensure that a blood vessel has not been entered.
After any insulin injection, the injection site should not be
massaged. Patients must be educated to use proper injection
techniques.
Humulin Mixture formulation is a ready-made defined mixture of soluble
and isophane insulin designed to avoid the need for
the patient to mix insulin preparations. A patient's treatment regimen
should be based on their individual metabolic
requirements.